Results 11 to 20 of about 172,507 (213)

Nonalcoholic fatty liver disease and cardiovascular disease phenotypes

SAGE Open Medicine, 2020
Nonalcoholic fatty liver disease is increasingly recognized as a major global health problem. Intertwined with diabetes, metabolic syndrome, and obesity, nonalcoholic fatty liver disease embraces a spectrum of liver conditions spanning from steatosis to ...
Giandomenico Bisaccia, Fabrizio Ricci, Cesare Mantini, Claudio Tana, Gian Luca Romani, Cosima Schiavone, Sabina Gallina   +6 more
doaj   +1 more source

Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease.

Hepatology, 2023
This commentary discusses how clinicians and various stakeholders can utilize the recently published American Association for the Study of Liver Diseases nonalcoholic fatty liver disease (AASLD NAFLD) Practice Guidance in light of the change in the ...
F. Kanwal, B. Neuschwander‐Tetri, R. Loomba, M. Rinella   +3 more
semanticscholar   +1 more source

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.

New England Journal of Medicine, 2021
BACKGROUND The prognoses with respect to mortality and hepatic and nonhepatic outcomes across the histologic spectrum of nonalcoholic fatty liver disease (NAFLD) are not well defined.
A. Sanyal, M. V. Van Natta, J. Clark, B. Neuschwander‐Tetri, A. Diehl, S. Dasarathy, R. Loomba, N. Chalasani, K. Kowdley, B. Hameed, L. Wilson, Katherine P. Yates, Patricia H. Belt, M. Lazo, D. Kleiner, Cynthia Behling, J. Tonascia   +16 more
semanticscholar   +1 more source

Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver DiseaseSummary

Cellular and Molecular Gastroenterology and Hepatology, 2023
Nonalcoholic fatty liver disease (NAFLD) is a fast growing, chronic liver disease affecting ∼25% of the global population. Nonalcoholic fatty liver disease severity ranges from the less severe simple hepatic steatosis to the more advanced nonalcoholic ...
Leke Wiering, Pallavi Subramanian, Linda Hammerich   +2 more
doaj   +1 more source

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments [PDF]

Clinical and Molecular Hepatology, 2023
Nonalcoholic fatty liver disease (NAFLD) affects approximately 30% of the population worldwide and includes nonalcoholic fatty liver, nonalcoholic steatohepatitis (NASH), and cirrhosis.
Sang Bong Ahn
doaj   +1 more source

Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease

JAMA Network Open, 2023
Key Points Question Is time-restricted eating more effective in improving nonalcoholic fatty liver disease than daily calorie restriction? Findings In this randomized clinical trial including 88 patients with obesity and nonalcoholic fatty liver disease,
Xueyun Wei, Bingquan Lin, Yan Huang, S. Yang, Chensihan Huang, Linna Shi, Deying Liu, Peizhen Zhang, Jiayang Lin, Bingyan Xu, D. Guo, Changwei Li, Hua He, Shi-qun Liu, Yao-ming Xue, Yi Xu, Huijie Zhang   +16 more
semanticscholar   +1 more source

Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis [PDF]

Терапевтический архив, 2019
Aim. Сomparative studying of changes in the spectrum of bile acids in bile in patients with nonalcoholic fatty liver disease and cholelithiasis. Materials and methods.
Ya M Vakhrushev, A P Lukashevich, I A Penkina, E V Suchkova   +3 more
doaj   +1 more source

Quality of Life in Patients with Nonalcoholic Fatty Liver Disease in Combination with Essential Hypertension

Львівський клінічний вісник, 2015
Introduction. Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases where its frequency in the population varies within 3.0–40.0 %.
Mashura H., Hanych T.
doaj   +1 more source

Global incidence and prevalence of nonalcoholic fatty liver disease

Clinical and Molecular Hepatology, 2022
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults
Margaret Teng, C. Ng, Daniel Q. Huang, K. Chan, Darren J. H. Tan, W. Lim, J. D. Yang, E. Tan, M. Muthiah   +8 more
semanticscholar   +1 more source

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Nature Genetics, 2008
Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem of unknown etiology that varies in prevalence among ancestry groups. To identify genetic variants contributing to differences in hepatic fat content, we carried out a genome-wide ...
S. Romeo, J. Kozlitina, Chao Xing, A. Pertsemlidis, David Cox, L. Pennacchio, E. Boerwinkle, Jonathan C. Cohen, H. Hobbs   +8 more
semanticscholar   +1 more source